Markets
Borrow
Earn
Invest
Private
Security
Newsroom
More
Log In
Sign Up
Markets
Market Overview
Indices and commodities.
Digital Credit
Bitcoin treasury preferreds.
AI Stocks
The artificial intelligence theme.
Bitcoin Treasuries
Companies holding bitcoin.
Economy
Sectors, global markets and rates.
Popular Portfolios
13F filings, smart money.
Borrow
Borrow
Borrow USDT or USDC against your BTC without giving it up.
ReFi
Switch your bitcoin-backed loan and pay less interest.
Earn
Carry Trade
Borrow, invest, keep the spread.
Stock Dividends
Dividends from tokenized equities.
Invest
Private
Security
Newsroom
More
Company
About Us
Our leadership team, mission, and investors.
Whitepaper
Vision, purpose, and architecture behind Roxom.
Legal
Terms, privacy, and disclosures.
Resources
Help Center
Guides, FAQs & support.
Rulebook
Trading logic, platform rules, and fundamentals.
API Docs
Connect, authenticate, and build with our API.
Status
Current platform health and incidents.
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
1 BTC
=
- USD
BTC
SATS
Loading market data...
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
Chart
Financials
Earnings
News
About
Dividends
Insider
Filings
BTC
SATS
USD
1d
1w
1m
6m
YTD
1y
5y
All
Loading chart
RE
RENX.LSE
RE
Renalytix AI plc
RENX.LSE
News
·
Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX
Mkt Cap
$36.5M
Volume
368.92K
Next Earnings
N/A
Chart
Financials
Earnings
News
About
Insider
Filings
Quest’s Expanded Alzheimer’s and Wellness Testing Push Might Change The Case For Investing In DGX
In recent months, Renalytix PLC, Humanity Health Inc., and Quest Diagnostics have announced new collaborations and product launches, including a nationwide kidneyintelX.dkd testing program, a Humanity Biological Age wellness add-on on questhealth.com, and expanded AD-Detect blood…
finance.yahoo.com · Sep 4, 2026
Carna Health Taps Multidisciplinary Healthcare and Technology Experts to Guide the Future of Cardio-Kidney-Metabolic Care
Strategic leadership additions support Carna Health's continued global growth, building on key partnerships and positioning the company for U.S. market entry BOSTON, August 27, 2026--(BUSINESS WIRE)--Carna Health, an AI-enabled digital health company revolutionizing Cardio-Kidney…
finance.yahoo.com · Aug 27, 2026
Renalytix Announces Collaboration with Tempus to Advance Intelligent Risk Assessment in Diabetic Kidney Disease
Definitive agreement to accelerate adoption of Renalytix's FDA-approved, Medicare reimbursed kidneyintelX.dkd test to slow kidney disease progression and improve patient outcomes NEW YORK, Sept. 15, 2025 /PRNewswire/ -- Renalytix plc (LSE: RENX) (OTCQB: RNLXY), today announced an…
finance.yahoo.com · Sep 15, 2025
MVP Health Care partners with Renalytix for kidney disease risk testing
NEW YORK - MVP Health Care and Renalytix plc (LSE:RENX) (OTCQB:RNLXY) announced Thursday a partnership to provide kidneyintelX.dkd testing to MVP’s 700,000 members in the northeastern United States. The collaboration aims to mitigate the progression of chronic kidney disease in M…
investing.com · Jul 17, 2025
New published data demonstrates KidneyIntelX™ has broad implications for winning war on chronic kidney disease
Renalytix plc Electronic health record deployment of KidneyIntelX was associated with clinical actions that slowed progression of chronic kidney disease and improved Type 2 diabetes control in just 12 months Results demonstrated a 61% increase in preventative drug prescriptions a…
finance.yahoo.com · Jan 10, 2024
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and advance value…
globenewswire.com · Nov 14, 2023
Renalytix Reports Financial Results for First Quarter of Fiscal Year 2024
Renalytix plc LONDON and SALT LAKE CITY, Nov. 14, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX), an artificial intelligence-enabled in vitro diagnostics company, focused on optimizing clinical management of kidney disease to drive improved patient outcomes and…
finance.yahoo.com · Nov 14, 2023
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
LONDON and SALT LAKE CITY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open. The Company will host a corresponding confer…
globenewswire.com · Nov 7, 2023
Renalytix to Report Financial Results for First Quarter Fiscal Year 2024 on November 14
Renalytix plc LONDON and SALT LAKE CITY, Nov. 07, 2023 (GLOBE NEWSWIRE) -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that it will report its first quarter fiscal year 2024 financial results on Tuesday, November 14, 2023, before market open. The Company will host a corres…
finance.yahoo.com · Nov 7, 2023
What Makes Renalytix AI PLC Sponsored ADR (RNLX) a New Strong Buy Stock
Renalytix AI PLC Sponsored ADR (RNLX) could be a solid addition to your portfolio given its recent upgrade to a Zacks Rank #1 (Strong Buy). This upgrade is essentially a reflection of an upward trend in earnings estimates -- one of the most powerful forces impacting stock prices.…
finance.yahoo.com · Oct 16, 2023
Holdings
Open Orders (0)
Positions (0)
Order History
Dividends
Transfers
Log In
to start trading
RE
RENX.LSE
Renalytix AI plc
Buy
Sell
Market
Limit
Soon
RENX.LSE
25%
50%
75%
Max
Pay with
—
Start Trading
Available Balance
0.00
Your Position
You don't own any RENX.LSE yet.
Related Tickers
Earnings